<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04491669</url>
  </required_header>
  <id_info>
    <org_study_id>GIT bleeding among CKD</org_study_id>
    <nct_id>NCT04491669</nct_id>
  </id_info>
  <brief_title>Screening of Gastrointestinal Tract Bleeding Causes Among Chronic Renal Failure Patients</brief_title>
  <official_title>Screening of Gastrointestinal Tract Bleeding Causes Among Chronic Renal Failure Patients in Assuit University in a Single Study Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the current study is to screen different causes and characteristics of&#xD;
      Gastrointestinal bleeding in Chronic Renal Failure patients at Assuit University Hospital&#xD;
      according to their stages based on e GFR (Stage I to IV), in order to assess different&#xD;
      modalities of therapeutic intervention from medical therapy up to therapeutic intervention.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Chronic Renal Failure is defined as presence of reduced glomerular filtration rate (GFR)&#xD;
           &lt; 60 ml/min/ 1.73 m2 and/or evidence of kidney damage (usually indicated by albuminuria&#xD;
           or proteinuria) for &gt; 3 months or more irrespective of cause (Kiapidou et al., 2019).&#xD;
&#xD;
        -  Chronic Renal Failure stages are classified according to the National Kidney Foundation&#xD;
           in to five stages according to estimated GFR (Ikizler 2009).&#xD;
&#xD;
        -  The prevalence of Chronic Renal Failure is continuously rising in concert with the&#xD;
           rising epidemic of its risk factors including ageing, diabetes, obesity, metabolic&#xD;
           syndrome, smoking, and hypertension (Stevens and Levin 2013).&#xD;
&#xD;
        -  Gastrointestinal bleeding, is all forms of bleeding in the gastrointestinal tract, from&#xD;
           the mouth to the rectum. When there is significant blood loss over a short time,&#xD;
           symptoms may include vomiting red blood, vomiting black blood, bloody stool, or black&#xD;
           stool. Small amounts of bleeding over a long time may cause iron-deficiency anemia&#xD;
           resulting in feeling tired or heart-related chest pain.&#xD;
&#xD;
      Other symptoms may include abdominal pain, shortness of breath, pale skin, or passing out.&#xD;
      Sometimes in those with small amounts of bleeding no symptoms may be present. (Bong Sik&#xD;
      Matthew Kim. 2014)&#xD;
&#xD;
      â€¢ Preliminary data suggest an association between Chronic Renal Failure and Gastrointestinal&#xD;
      Bleeding. Individuals with even mild to moderate Chronic Renal Failure warrant clinical&#xD;
      attention regarding the risk of hospitalization with Gastrointestinal bleeding. (Kunihiro&#xD;
      Matsushita, 2016 Oct 7) reported that the prevalence of Gastrointestinal bleeding was&#xD;
      significantly higher in patients with Chronic Renal Failure compared to patients without&#xD;
      Chronic Renal Failure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of different modalities of therapeutic intervention.</measure>
    <time_frame>one year from October 2020 to October 2021</time_frame>
    <description>medical therapy up to therapeutic intervention data will be received.</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>CKD</condition>
  <condition>GIT - Gastrointestinal Tract Hemorrhage</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>GFR - Glomerular Filtration Rate</intervention_name>
    <description>Chronic Renal Failure staging according to GFR by Chronic Renal Failure EPI is:&#xD;
Stage1 in which GFR&gt;90 mil/min but evidence of kidney damage.&#xD;
Stage 2 GFR 60-89 mil/min.&#xD;
Stage 3 GFR 30-95 mil/min.&#xD;
Stage 4 GFR 15-29 mil/min.&#xD;
Stage 5 GFR&lt;15 mil/min.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Chronic Renal Failure patients with different stages (stage I to IV) according to the&#xD;
        National Kidney Foundation are recruited from inpatients of renal unit in internal medicine&#xD;
        department, Assuit university hospitals.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  One hundred Chronic Renal Failure patients with different stages (stage I to IV)&#xD;
             according to the National Kidney Foundation are recruited from inpatients of renal&#xD;
             unit in internal medicine department, Assuit university hospitals. Their GFR will&#xD;
             assessed by using Chronic Renal Failure EPI equation measured as GFR=166 x(s&#xD;
             cr/0.7)-1.209X(0.993)age if female, and GFR=163X(s cr/0.9)-1.209x(0.993)age if male.&#xD;
             (Andrews et al 2008).&#xD;
&#xD;
        Chronic Renal Failure staging according to GFR by Chronic Renal Failure EPI is:&#xD;
&#xD;
          -  Stage1 in which GFR&gt;90 mil/min but evidence of kidney damage.&#xD;
&#xD;
          -  Stage 2 GFR 60-89 mil/min.&#xD;
&#xD;
          -  Stage 3 GFR 30-95 mil/min.&#xD;
&#xD;
          -  Stage 4 GFR 15-29 mil/min.&#xD;
&#xD;
          -  Stage 5 GFR&lt;15 mil/min.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  All Patients with local causes of Gastrointestinal Bleeding&#xD;
&#xD;
               -  Benign and Malignant tumors in Gastrointestinal Tract.&#xD;
&#xD;
               -  Patients with Hemorrhoids or anal fissures.&#xD;
&#xD;
               -  Patients with Mallory-Weiss tears.&#xD;
&#xD;
               -  patients with Diverticular disease.&#xD;
&#xD;
               -  patients with Colon polyps.&#xD;
&#xD;
               -  patients with infectious causes of GIT bleeding (Salmonella, Shigella)&#xD;
&#xD;
               -  patients with Angiodysplasia.&#xD;
&#xD;
               -  patients with Esophageal varices&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Effat AH Tony, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahmoud EMH Mandou</last_name>
    <phone>00201006810538</phone>
    <email>m1234mandour@outlook.com</email>
  </overall_contact>
  <reference>
    <citation>Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, Sinclair P; International Consensus Upper Gastrointestinal Bleeding Conference Group. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010 Jan 19;152(2):101-13. doi: 10.7326/0003-4819-152-2-201001190-00009.</citation>
    <PMID>20083829</PMID>
  </reference>
  <reference>
    <citation>Zuccaro G Jr. Management of the adult patient with acute lower gastrointestinal bleeding. American College of Gastroenterology. Practice Parameters Committee. Am J Gastroenterol. 1998 Aug;93(8):1202-8.</citation>
    <PMID>9707037</PMID>
  </reference>
  <reference>
    <citation>Kim BS, Li BT, Engel A, Samra JS, Clarke S, Norton ID, Li AE. Diagnosis of gastrointestinal bleeding: A practical guide for clinicians. World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):467-78. doi: 10.4291/wjgp.v5.i4.467. Review.</citation>
    <PMID>25400991</PMID>
  </reference>
  <reference>
    <citation>Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013 Jun 4;158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007.</citation>
    <PMID>23732715</PMID>
  </reference>
  <reference>
    <citation>Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clin Exp Nephrol. 2019 Apr;23(4):437-447. doi: 10.1007/s10157-018-1641-8. Epub 2018 Sep 3. Review. Erratum in: Clin Exp Nephrol. 2019 Mar 2;:.</citation>
    <PMID>30178234</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 25, 2020</study_first_submitted>
  <study_first_submitted_qc>July 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2020</study_first_posted>
  <last_update_submitted>July 28, 2020</last_update_submitted>
  <last_update_submitted_qc>July 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mahmoud Elsayed Mustafa Hussein Mandour</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

